
Does Ambien Clutter the Brain with Alzheimer’s Plaque?
Ambien (Zolpidem), a sleeping pill, was studied to see its effects on the brain. Learn to think twice before reaching for a sleeping pill – while you can still think clearly.
Ambien (Zolpidem), a sleeping pill, was studied to see its effects on the brain. Learn to think twice before reaching for a sleeping pill – while you can still think clearly.
Newer blood tests accurately predict Alzheimer’s. This opens the door to earlier detection and treatment. Be cautious: only taking these tests with guidance from a medical expert.
Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.
Leqembi and Kisunla are the new Alzheimer’s immunotherapies. A loss of brain volume associated with these immunotherapies may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue. A new study sheds light on what’s going on.
A trio of key studies identified predictors of dementia risk, the benefits of detecting cognitive impairment early and identified barriers to routine cognitive screening in older adults, such as cost. See their recommendations.
How much protection can frequent spatial processing tasks offer against Alzheimer’s? Researchers in The British Medical Journal investigate.
A new study shows ultrasound improves memory even when amyloid plaque levels don’t improve. (Amyloid is the culprit behind Alzheimer’s.) Could ultrasound be the missing piece in the Alzheimer’s puzzle?
Ketones are a backup source of energy for neurons. Now, exciting research reveals bigger news: Ketone esters help clear misfolded proteins in animal models of aging and Alzheimer’s.
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?
Japanese researchers develop a simple test for diagnosing Alzheimer’s quickly, easily, with 83% accuracy.
Talk therapy may improve symptoms of depression for people with dementia, providing hope for those who typically do not benefit from antidepressant medication.
“Damn this old dementia, for robbing me of time, But I promise you forever, you will never leave my mind.”
VIDEO ON SUNDOWNING: See UCLA’s Dementia Care Program deal with end-of-day agitation and irritability, known as “Sundowning”. A caregiver asks, “My loved one’s behavior tends to get worse when the sun starts to go down. He appears exhausted and restless. What can I do to get him through this time of the day?”
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.